ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium bis(trimethylsilyl)amide → 1-[2(R)-[1(S)-(tert-butoxycarbonyl)-2-(3,4,4-trimethyl-2,5-dioxo-1imidazolidinyl)ethyl]-3-cyclopentylpropionyl]piperidine

HRID 429521
印刷

反応式

HRID 429521 の反応式
C[Si]([N-][Si](C)(C)C)(C)C.[K+].BrCN1C(=O)C(C)(C)N(C)C1=O.[C:23]([O:27][C:28]([C@H:30]([C@@H:42]([CH2:51][CH:52]1[CH2:56][CH2:55][CH2:54][CH2:53]1)[C:43]([N:45]1[CH2:50][CH2:49][CH2:48][CH2:47][CH2:46]1)=[O:44])[CH2:31][N:32]1[C:36](=[O:37])[C:35]([CH3:39])([CH3:38])[N:34]([CH3:40])[C:33]1=[O:41])=[O:29])([CH3:26])([CH3:25])[CH3:24]>O1CCCC1>[C:23]([O:27][C:28]([C@@H:30]([C@@H:42]([CH2:51][CH:52]1[CH2:53][CH2:54][CH2:55][CH2:56]1)[C:43]([N:45]1[CH2:46][CH2:47][CH2:48][CH2:49][CH2:50]1)=[O:44])[CH2:31][N:32]1[C:36](=[O:37])[C:35]([CH3:38])([CH3:39])[N:34]([CH3:40])[C:33]1=[O:41])=[O:29])([CH3:24])([CH3:25])[CH3:26]
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 3251421Potassium bis(trimethylsilyl)amideHCID 98050521-[2(R)-[1(R)-(tert-butoxycarbonyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]-3cyclopentylpropionyl]piperidineHCID 109334353-Bromomethyl-1,5,5-trimethylhydantoin

生成物 1

HCID 233822641-[2(R)-[1(S)-(tert-butoxycarbonyl)-2-(3,4,4-trimethyl-2,5-dioxo-1imidazolidinyl)ethyl]-3-cyclopentylpropionyl]piperidine収率 78%

試薬・触媒・溶媒

1
HCID 8028Tetrahydrofuran溶媒

実験手順

A solution of 10.7 g of the ester from Example 3 in 50 ml of tetrahydrofuran was added dropwise at −60° to a solution of 8.76 g of potassium bis-trimethylsilylamide in 80 ml of tetrahydrofluran and the mixture was stirred at −60° for 30 min. Subsequently, a solution of 7.76 g of 3-bromomethyl-1,5,5-trimethylhydantoin in 40 ml of tetrahydrofliran was added at −60° and the mixture was stirred at −60° for 30 min. The reaction mixture was washed with semi-saturated sodium chloride solution and with dilute hydrochloric acid, dried, filtered and concentrated, there being obtained 15.11 g of a 9:1 mixture of 1-[2(R)-[1(R)-(tert-butoxycarbonyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]-3cyclopentylpropionyl]piperidine and 1-[2(R)-[1(S)-(tert-butoxycarbonyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]-3-cyclopentylpropionyl]piperidine (78% yield of pure anti-compound), which was used in the next step without further purification. The mixture can be separated by chromatography on silica gel with hexane/ethyl acetate (1:1).

後処理

  1. stirringthe mixture was stirred at −60° for 30 min
  2. washThe reaction mixture was washed with semi-saturated sodium chloride solution and with dilute hydrochloric acid
  3. customdried
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customthere being obtained

出典と根拠

ORDレコード
ord-28ec5c0c3e134616bb2f1027255682e3
出典データセット
uspto-grants-2001_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06316633B1

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート